Drug Master Files for: RUFINAMIDE
✉ Email this page to a colleague
RUFINAMIDE Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
25676 | A | II | 1/4/2012 | DIPHARMA FRANCIS SRL | RUFINAMIDE USP |
26209 | A | II | 10/23/2012 | GLENMARK PHARMACEUTICALS LTD | RUFINAMIDE |
26316 | A | II | 10/9/2012 | LUPIN LTD | RUFINAMIDE USP |
26385 | A | II | 9/29/2012 | MSN LABORATORIES PRIVATE LTD | RUFINAMIDE USP [ROUTE CODE RU] |
28284 | I | II | 5/9/2014 | ZHEJIANG JIUZHOU PHARMACEUTICAL CO LTD | RUFINAMIDE |
29034 | A | II | 3/27/2015 | APOTEX PHARMACHEM INC | RUFINAMIDE USP |
32713 | A | II | 4/30/2018 | MSN LIFE SCIENCES PRIVATE LTD | RUFINAMIDE USP |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information